0001104659-20-001551.txt : 20200106 0001104659-20-001551.hdr.sgml : 20200106 20200106163557 ACCESSION NUMBER: 0001104659-20-001551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WESSON BRUCE F CENTRAL INDEX KEY: 0001058190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 20510221 MAIL ADDRESS: STREET 2: 1827 PACIFIC ST CITY: BROOKLYN STATE: NY ZIP: 11233 FORMER NAME: FORMER CONFORMED NAME: WESSON BRUCE T DATE OF NAME CHANGE: 19980319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 4 1 tm201246d1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-01-02 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001058190 WESSON BRUCE F C/O ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 1 0 0 0 Common Stock 2020-01-02 4 M 0 83333 A 603926 D Restricted Stock Units (2017 Plan) 2020-01-02 4 M 0 83333 D Common Stock 83333 0 D Restricted Stock Units (2017 Plan) 2020-01-02 4 A 0 54790 A Common Stock 54790 54790 D Represents exchange of restricted stock units. Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock Does not include Restricted Stock Units. 1 - for - 1 25% of Restricted Stock Units vested on March 31, 2019, 25% vested on June 30, 2019; 25% vested on September 30, 2019 and 25% vested on December 31, 2019. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value. N/A 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2020, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2021, or earlier upon a change of control. /s/ Bruce Wesson 2020-01-06